Peter Hebert

Peter co-founded Lux Capital with the idea that in order to have the biggest impact on the future, one should support the most scientifically and technologically ambitious ventures. Peter led Lux’s investments in Auris Health (acquired by Johnson & Johnson (JNJ) for up to $6.05 billion, making it one of top 10 VC-backed private M&A transactions of all-time), Lux Research (acquired by Private Equity), Luxtera (acquired by Cisco (CSCO) for $660 million), and SiBEAM (acquired by Silicon Image (SIMG)). Current investments include Avail, Bright Machines, Everspin Technologies (MRAM), Flex Logix, Halo Neuroscience, Matterport, Ripcord, Transphorm, and Vium. In 2003, Peter led the spin-off of Lux Research. As its founding CEO, he helped build Lux Research into the leading emerging-technology research firm. Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. He was a Chancellor’s Scholar and graduated cum laude from Syracuse University’s Newhouse School, and was the Founding President of its first venture organization, Future Business Leaders and Entrepreneurs. He has been a guest on CNBC and Bloomberg TV, and speaker at Columbia, Cornell, MIT, Stanford, Yale, and the National Science Foundation.